Not recruiting
Acute myeloid leukaemia refractory+3
Not recruitingRegistered drugNo placebo
Study of S227928 Alone and with Venetoclax for Patients with Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Registered drugNo placebo
- Disease:Acute myeloid leukaemia refractoryAcute myeloid leukaemia recurrent+2
- Substances:AllopurinolRasburicase+2
Countries:
Finland
Finland- Participants:18–64 years · 65+ years
- Substances:Allopurinol
- Sponsor:Institut De Recherches Internationales Servier IRIS


